编者荐语： 日经中文网与36氪开展内容交换合作。将精选36氪的精彩独家财经、科技、企业资讯，与读者分享。 以下文章来源于36氪Pro ，作者剡沛 36氪Pro . 像缝纫机一样，以每1.5秒一次的速度，把 它们"缝"进你的脑组织。 文 ｜ 剡沛 封面来源 ｜ 日经中文网 给你的脑壳开个洞，每1.5秒，往里面扎一针，就这样连扎128次。这就是马斯克脑机接口公司，最新公布的手术。 请观看36氪原创视频 也欢迎关注36氪视频号 没错，这次视频足足有20分钟，把脑机接口手术的全过程，还有最新的手术机器人，全部公开了。手术过程出奇的简单，就是医生先在你脑壳上，开个硬币大小的洞，脑组织露出来，把这个脑机接口设备放进去 。 但总得把什么东西插进脑子里吧？你看，这个设备上连着的100多根电极线，这每一根线比红细胞还细 。 每根线上又有8个电极，总通道数量高达1000个，探测大脑皮层信号简直易如反掌 。 怎么插这些线呢？ 重磅主角登场：Neuralink的手术机器人 。 这玩意儿正好有一根比红细胞还细的针头，一根一根抓起这100多根电线 。 像缝纫机一样，以每1.5秒一次的速度 ， 把它们"缝"进你的脑组织。 这画面看着都疼。 ...

Core Viewpoint - The brain-computer interface (BCI) market is poised for rapid growth driven by policy and technological advancements, with a projected market size reaching $7.63 billion by 2029 from $2 billion in 2023, indicating a significant opportunity in this emerging sector [4]. Group 1: Policy and Market Dynamics - Major countries are launching initiatives to support BCI development, with the U.S. investing approximately $4.5 billion in its "Brain Initiative" and China planning to allocate hundreds of billions in funding for brain science research [4]. - The Chinese government has set clear targets for BCI technology breakthroughs by 2027 and the establishment of a complete industry ecosystem by 2030 [4]. Group 2: Clinical Applications and Growth - The medical sector is currently the most developed application area for BCI technology, focusing on neurorehabilitation, functional replacement, and disease treatment [5]. - The integration of BCI devices into healthcare is expected to be facilitated by insurance pricing policies, which will enhance the commercialization of these technologies [5]. - Both invasive and non-invasive BCI products are entering clinical trials or receiving market approval, with invasive technologies showing promise in restoring motor functions for paralyzed patients [5]. Group 3: Domestic Industry Development - Despite the lead of foreign companies, domestic firms are accelerating the localization of BCI technologies, particularly in flexible electrodes and real-time language decoding [6]. - The industry chain is evolving with upstream breakthroughs, midstream integration of devices and algorithms, and downstream applications expanding into pediatrics and psychiatry [6]. - Cities like Shanghai and Beijing are expected to develop into industrial clusters for BCI technology [6].

Investment Rating - The report maintains an "Overweight" rating for the biomedical sector [4] Core Insights - The brain-computer interface (BCI) industry is at a critical stage of policy support, rapid technological iteration, and accelerated commercialization, with a global market approaching $10 billion [3][9] - The industry is driven by both policy and technology, with significant investments from major countries, including approximately $4.5 billion from the U.S. BRAIN Initiative and hundreds of billions in China [1][51] - The medical application of BCI technology is the most mature segment, focusing on neurorehabilitation, functional replacement, and disease treatment, with a dual growth curve emerging from medical and consumer applications [2][45] Summary by Sections Industry Overview - BCI is defined as a technology that creates a communication channel between the brain and external devices, enabling direct information exchange [16] - BCI can be categorized into invasive, semi-invasive, and non-invasive types, each with distinct applications in medical rehabilitation, consumer interaction, and military use [17][19] - The global BCI market is projected to grow from $1.2 billion in 2019 to approximately $7.63 billion by 2029, with a compound annual growth rate (CAGR) exceeding 13% [24] Policy Guidance - Major countries have launched BCI-related initiatives, with the U.S. and EU leading in funding and research efforts [52][53] - China's "Brain Plan" aims to enhance brain science and BCI technology, with significant funding expected in the coming years [54][57] Clinical Applications - The medical sector is the primary focus for BCI applications, with significant demand driven by conditions such as stroke and disabilities [45][48] - Clinical trials for BCI products are accelerating globally, with notable advancements in both invasive and non-invasive technologies [3][19] Industry Progress - The report highlights the competitive landscape, noting that while foreign companies like Neuralink and Synchron have a head start, domestic firms are making significant strides in key areas such as flexible electrodes and real-time language decoding [2][4][30] - The BCI industry is characterized by a complex supply chain, with upstream components like electrodes and chips, midstream product supply, and downstream applications across various sectors [30][33] Investment Recommendations - Investors are advised to focus on companies with strong technological barriers and clinical application capabilities, particularly in the medical sector, which is the most developed area for BCI commercialization [3][9] - Specific companies to watch include medical scene integrators and leaders in invasive/semi-invasive technologies, such as Xiangyu Medical, Weisi Medical, and Brain Tiger Technology [3][9]

Group 1 - Humanoid robots are seen more as fundraising and marketing gimmicks rather than being ready for large-scale production by 2026, as they are still in the exploration phase of training data and application models [1] - Fully autonomous driving is expected to become a reality in 2026, with Tesla achieving complete driverless operation in Texas and at least one other state [1] - The low-altitude robotics market is anticipated to experience accelerated growth due to advancements in AI autonomous flight capabilities and a gap in commercial drone usage in the U.S. [1] - The U.S. federal government is predicted to expedite the rollout of autonomous driving regulations, with a potential policy window emerging in 2026 [1] - Traditional automakers are expected to fully embrace robotics, following companies like BYD, Xiaomi, and Xpeng, with more entering the robotics industry starting in 2026 [1] - A new "competitive cooperation" dynamic is expected to form between China and the U.S. in the robotics sector, with China’s advantages in advanced manufacturing and supply chains making it a key partner for U.S. robotics firms [1] Group 2 - Tesla's robotics factory is projected to become the "mother" of the next-generation robotics system, with xAI's computational power and "truth-seeking AI" significantly enhancing the value of robotic systems [2] - The first trillion-dollar unicorn in the robotics field is anticipated to emerge in the coming years, primarily focusing on the integration of embodied intelligence and high-performance computing [2] - The "Mag 7" companies, including Apple, Google, Amazon, Meta, and Microsoft, are expected to frequently mention terms like "robot," "humanoid," and "embodied" in their earnings calls over the next year [2] - Brain-computer interfaces (BCI) are projected to make significant advancements towards "superhuman capabilities," with companies like Neuralink expected to achieve major clinical breakthroughs by 2026, particularly in the video game sector [2]

脑机接口板块大涨，建议加强重视十五五规划医疗科技方 向 20251225 摘要 中国在脑机接口领域处于全球相对领先地位。中国拥有大量医院和病人资源， 积极推动先进疗法的临床试验。此外，中国在医疗器械制造方面积累了丰富经 验，有望实现厚积薄发。目前，中国有许多团队从事脑机接口研究，数量甚至 可能超过美国。未来，中国有望涌现出具有全球竞争力的脑机接口公司，并逐 步走向国际市场。 目前有哪些公司在布局脑机接口领域？ 在上游零部件供应方面，美好医疗等公司为脑机接口企业提供代工服务。在康 复医疗器械领域，公司如翔宇医疗、迈兰德、韦斯和诚益通等都在积极布局。 此外，下游医院如三博脑科也非常重视这一方向。在非侵入式脑机接口方面， 强脑科技等公司备受关注。一级市场中，如博瑞康等公司也被寄予厚望，有望 通过上市形成更强的板块效应。 明年（2026 年）可以期待哪些政策支持？ 中国脑机接口领域发展迅速，受益于庞大的医院和病人资源以及医疗器 械制造经验，涌现出众多研究团队，数量或超美国，未来有望出现具全 球竞争力的公司。 政策支持力度加大，预计 2026 年将迎来国家顶层设计、资金支持以及 药监局绿色通道等多方面政策利好，加速产品 ...

每经记者｜兰素英 每经编辑｜高涵 "就在那一刻，这项技术在我眼中彻底变成了科幻般的存在。" 当诺兰·阿博（Noland Arbaugh）第一次仅凭意念移动电脑光标时，发出了这番感慨。 2016年，诺兰·阿博因跳水事故导致肩部以下失去活动能力。2024年1月28日，他接受了埃隆·马斯克旗下脑机接口公司Neuralink的Link芯片植入手术，成为 实验的"一号受试者"。 23个月后，这枚被他命名为"Eve"的硬币大小的设备，不仅让他重新连接了数字世界，更重要的是，正让他从"家人的累赘"一步步走向生活的独立，并有 望成为首位"双植入"患者。 近日，诺兰·阿博接受了《每日经济新闻》记者（以下简称NBD）独家专访。从最初仅凭意念移动光标的"科幻时刻"，到脑机接口技术带给自己的变化， 再到该技术的伦理问题，这位"脑机人"分享了他的独特经历、心路历程与深层思考。 谈意念控制初体验：太科幻了 诺兰·阿博 图片来源：受访者供图 NBD：当你第一次仅凭意念操控电脑光标时，有什么感受？ 诺兰·阿博：这种体验分成两个阶段。 第一阶段，我并没有像大家想象的那样感到无比震撼。 日前，Neuralink技术迭代加速，植入单根电极线的时间 ...

Core Insights - Elon Musk has become the world's first individual with a net worth exceeding $700 billion, primarily due to the reinstatement of $139 billion in Tesla stock options by the Delaware Supreme Court, which boosted his wealth to $749 billion [1] Group 1: Wealth Accumulation Stages - The first stage of Musk's wealth accumulation involved the founding of Zip2 in 1995, which was sold for $307 million in 1999, allowing him to invest in X.com, which later became PayPal, sold to eBay for $1.5 billion in 2002 [4][8] - The second stage saw Musk invest heavily in SpaceX and Tesla, with SpaceX aiming to reduce space transportation costs significantly and Tesla transforming electric vehicles into sustainable transportation options [9][11] - The third stage focuses on creating an interconnected ecosystem, including sustainable energy solutions through Tesla's acquisition of SolarCity and ventures into transportation and AI technologies [12][14] Group 2: Strategic Insights - Musk's approach combines first-principles thinking with extreme ambition and capital artistry, leading to a unique ability to identify industry pain points and construct viable solutions [3][8] - His wealth growth strategy shifted from linear software iterations to "vision capitalization," where achieving seemingly impossible technological breakthroughs attracted significant market valuations [11][15] - Musk's philosophy transcends traditional wealth accumulation, emphasizing the importance of leveraging time, risk, narrative, and innovative thinking to achieve long-term goals [14][16][19]

美好医疗 20151223 摘要 美好医疗以医疗器械 CDMO 业务为主，战略方向包括血糖监测、IVD、 心血管及骨科等领域，并积极布局脑机接口和人形机器人等新兴业务。 公司利用在人工耳蜗组件制造方面的技术积累，延伸至脑机接口植入体 制造与代工，已取得一定规模收入，并计划在非侵入式、半侵入式及侵 入式脑机接口领域全面发力。 美好医疗具备全产业链精密制造能力，包括 NPI 开发、模具制造、注塑 和挤出工具生产，以及自主开发自动化设备的能力，并通过国际体系认 证及市场准入认证，确保产品质量。 公司研发投入占总营收的 9%左右，脑机接口产品研发主要集中在人工 耳蜗技术的转产和量产，人工耳蜗植入体毛利率在 60%-70%之间，脑 机接口产品参考此毛利水平。 美好医疗在材料学及生物相容性处理方面具有优势，是全球最大的人工 耳蜗上游供应商之一，并与海外头部企业（如 Neuralink）展开技术探 讨，未来或有合作机会。 Q&A 请介绍一下美好医疗的业务布局和发展方向。 美好医疗是一家专注于医疗器械的 CDMO 企业，业务主要分为三大板块。第一 是传统业务，包括呼吸机组件和人工耳蜗组件，这些产品的客户都是全球细分 领域的龙 ...

Core Insights - Elon Musk became the first individual in history to surpass a net worth of $700 billion, reaching $749 billion, largely due to a court ruling that restored his 2018 Tesla stock options valued at $139 billion [1][5] - The wealth gap between Musk and the second richest individual, Larry Page, has widened to nearly $500 billion, equivalent to the annual GDP of a medium-developed country [1] - Musk's rapid wealth accumulation is indicative of a fundamental shift in how wealth is generated in the modern economy, moving away from traditional profit-sharing to being heavily tied to equity valuations [5][10] Group 1: Wealth Accumulation Factors - Musk's wealth surge was catalyzed by a Delaware Supreme Court ruling that reinstated a compensation plan granting him approximately 170 million Tesla stock options, which saw a dramatic increase in value as Tesla's stock price rose from around $200 to nearly $800 [5][6] - The valuation of SpaceX has skyrocketed to nearly $800 billion, increasing over 22 times since March 2020, with potential for further increases if the company goes public [6][10] - The approval of a $1 trillion compensation plan by Tesla shareholders in November 2024 marks the largest corporate incentive scheme in history, reflecting investor confidence in Musk's vision rather than past profits [6][10] Group 2: Market Dynamics and Valuation - The current wealth accumulation model for top billionaires is increasingly reliant on unrealized capital gains rather than traditional cash flow from business operations, leading to a rapid increase in "paper wealth" [5][10] - The digital economy's network effects allow for exponential growth in company valuations, as seen with Tesla, which operates not just as a car manufacturer but also as an energy network and AI training infrastructure [9] - The liquidity provided by modern financial instruments enables quick monetization of equity in private companies, allowing Musk to realize parts of his wealth without needing to wait for public offerings [9][10] Group 3: Future Implications - Musk's wealth growth signifies the onset of an era characterized by "super individual wealth," where top tech entrepreneurs can accumulate wealth at rates far exceeding historical figures like Rockefeller, Gates, and Bezos [10] - The sustainability of this wealth accumulation model is questioned, as it heavily relies on market sentiment and legal decisions rather than tangible productivity contributions [10][11]

Core Insights - Brain-Computer Interface (BCI) technology is emerging as the "ultimate physical embodiment" of artificial intelligence, aimed at addressing medical challenges and serving as a key bridge for human-AI coexistence, with significant long-term market potential attracting global capital and enterprises [1][4] Market Potential - Morgan Stanley's report estimates that the total addressable market (TAM) for BCI implant devices in the U.S. could reach $80 billion by 2035 and soar to $320 billion by 2045, primarily targeting treatments for various neurological disorders such as ALS, stroke, spinal cord injuries, epilepsy, and depression [1][12] Competitive Landscape - A global competitive landscape is forming, with key players including Neuralink, Synchron, Precision, and Paradromics. China has announced a BCI technology development roadmap aiming for key breakthroughs by 2027 and to become a global leader by 2030 [4][12] Historical Context - The development of BCI is not new, tracing back to the discovery of brain electrical activity by Hans Berger in 1924, with significant advancements occurring in the early 21st century, such as the demonstration by Duke University's Miguel Nicolelis in 2003, where a monkey controlled a robotic arm via BCI [5] Technological Pathways - Current BCI implantation techniques include Neuralink's robotic surgery to insert threads into the motor cortex, Synchron's vascular electrode array implantation, and micro-invasive techniques from Precision and Paradromics [5] Neuralink's Vision - Elon Musk has set a four-tiered vision for Neuralink: first, to alleviate human suffering (e.g., "mind-reading" implants for paralyzed patients); second, to enhance human capabilities (e.g., future "blindness" implants); third, to understand and expand consciousness; and finally, to achieve human coexistence with AI/robots to mitigate existential risks posed by AI [9][11] Investment Trends - Investment in neurotechnology, including BCI, surged to approximately $1.8 billion by the end of 2025, indicating high capital interest. Neuralink leads with a valuation of $9 billion and over $1.3 billion in funding [12] Future Outlook - The report outlines a shift from technological exploration to commercialization and large-scale application of embodied AI, redefining productivity and human capabilities, and presenting a vast, multi-layered market landscape for investors [23]